ARCHIVES

Wistar Investigators Report Oncogene Relation to Burkitt’s

This article is from The Cancer Letter archive.

Vol. 08 No. 46 | November 26, 1982

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month

March 29, 2002

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

Army Plans Solicitation For Breast Cancer Research Proposals

April 21, 1995

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977